Febuxostat hemihydrate is a crystalline form of febuxostat, a non-purine selective inhibitor of xanthine oxidase used to treat hyperuricemia in patients with gout. It is grouped under the following drug class(es): Gout agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Febuxostat hydrate. Its PubChem CID is 56963122.
Febuxostat hemihydrate
| CAS No | 442664-09-7 |
|---|---|
| Molecular Formula | C32H34N4O7S2 |
| Molecular Weight | 650.8 g/mol |
| Synonyms | bis(2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid);hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Febuxostat hemihydrate is a crystalline form of febuxostat, a non-purine selective inhibitor of xanthine oxidase used to treat hyperuricemia in patients with gout.
The listed CAS number is 442664-09-7.
The listed molecular formula is C32H34N4O7S2.
The listed molecular weight is 650.8 g/mol.
bis(2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid);hydrate.
The source lists Febuxostat hydrate.